JAMP-SENNA S 50 MG
DOCUSATE SODIUM : 50 MG SENNOSIDES : 8.6 MG · DIN 02291215 · JAMP PHARMA CORPORATION
Health Canada status: DORMANT
What is JAMP-SENNA S?
JAMP-SENNA S 50 MG contains DOCUSATE SODIUM : 50 MG SENNOSIDES : 8.6 MG. It is listed in the Health Canada Drug Product Database under DIN 02291215, held by JAMP PHARMA CORPORATION, supplied as TABLET for ORAL administration. Health Canada currently lists it as dormant, status dated 07-Aug-2017. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02291215 |
|---|---|
| Brand name | JAMP-SENNA S |
| Generic / active ingredient | DOCUSATE SODIUM : 50 MG SENNOSIDES : 8.6 MG |
| Manufacturer | JAMP PHARMA CORPORATION |
| Strength | 50 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | A06AB56 SENNA GLYCOSIDES, COMBINATIONS |
| AHFS class | 56:12.00 |
| Biosimilar | No |
| Health Canada status | DORMANT |
| Status date | 07-Aug-2017 |
| Original market date | 2010-10-25 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code A06AB56 SENNA GLYCOSIDES, COMBINATIONS. 5 of 18 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| COLACE PLUS STIMULANT LAXATIVE | 8.6 MG | TABLET | PHARMASCIENCE INC | MARKETED | DIN 02516209 |
| SENNA LAXATIVE AND DOCUSATE SODIUM TABLETS | 50 MG | TABLET | VITA HEALTH PRODUCTS INC | MARKETED | DIN 02247134 |
| SENNA S. TABLETS | 8.6 MG | TABLET | SIGMA LIFE SCIENCES INC. | MARKETED | DIN 02246951 |
| SENOKOT S | 50 MG | TABLET | INOVA PHARMACEUTICALS (SINGAPORE) PTE. LTD. | MARKETED | DIN 00026123 |
| TIMELY SENNOSIDES 8.6 MG AND DOCUSATE SODIUM 50 MG TABLETS | 50 MG | TABLET | TIME-CAP LABORATORIES, INC | MARKETED | DIN 02553007 |
| CENNLACS | 182 MG | POWDER | WESTWARD DISTRIBUTORS | CANCELLED POST MARKET | DIN 00552682 |
| DOCUSEN | 100 MG | TABLET | JAMP PHARMA CORPORATION | APPROVED | DIN 02371650 |
| EX-LAX GENTLE STRENGTH | 65 MG | TABLET | NOVARTIS CONSUMER HEALTH CANADA INC. | CANCELLED POST MARKET | DIN 02241666 |
| LAXATIF DE SENE ET DOCUSATE DE SODIUM | 8.6 MG | TABLET | PHARMALAB INC. | CANCELLED PRE MARKET | DIN 02270293 |
| LAXATIVE PLUS SOFTENER | 8.6 MG | TABLET | CELLCHEM PHARMACEUTICALS INC. | APPROVED | DIN 02322420 |
Who else supplies SENNA GLYCOSIDES, COMBINATIONS worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. SENNA GLYCOSIDES, COMBINATIONS appears in 21 registered pack listings across 3 markets, published on 3 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.